TIDMKRS
RNS Number : 7377F
Keras Resources PLC
22 May 2017
Keras Resources plc / Index: AIM / Epic: KRS / Sector:
Mining
22 May 2017
Keras Resources plc
("Keras" or the "Company")
Interim Results
Keras Resources plc, the AIM listed mineral resource company, is
pleased to announce its interim results for the six months ended 31
March 2017.
HIGHLIGHTS
Development of a strategic multi-commodity mining portfolio:
-- Targeting listing of Australian gold assets on the ASX in
June 2017 to establish a standalone listed entity on a market which
has demonstrated significant interest for domestic resource
projects:
o Completed the acquisition of the Klondyke gold project
("Klondyke") in October 2016, subsequently expanded to form the
Warrawoona Gold Project ('Warrawoona');
o Established significant gold inventory of 5.8Mt @ 2.2g/t gold
for 410,000oz with significant further upside;
o ASX quoted Pharmanet Group Limited ('Pharmanet') to acquire
100% of Keras Australia and change name to Calidus Resources (the
"Transaction");
o Oversubscribed placing from sophisticated investors in
Australia raised A$620,000 for Pharmanet - underpinning support for
the Transaction;
o General meeting of Keras shareholders to be held in the UK on
24 May 2017 to approve the Transaction; and
o Pharmanet to raise A$7.9 million with the re-listing of
Calidus Resources on the ASX in June 2017.
-- Gaining exposure to the high-growth battery industry through
the development of three complementary commodities in Togo: cobalt,
nickel and manganese:
o Awaiting mining licence for 11.0Mt @ 13.1% manganese Nayega
project - seeking to develop an initial open-pit, 250,000tpa
manganese operation;
o Expanded mineral footprint through the application for five
exploration licences, which have known cobalt and nickel
mineralisation outcropping at surface:
-- Exploration underway;
-- Cobalt often reported as the most critical metal from a
supply perspective for the battery industry - prices have increased
100% in the past six months.
-- Capital raisings of GBP600,000 (before expenses) in February
2017 to support ongoing exploration work at Warrawoona, and, of
GBP530,000 (before expenses) in April 2017 to support the
Transaction and the Group's manganese and cobalt projects.
Chairman's Statement
2017 to-date has been a year of change and development for
Keras, centred around the planned listing of our Australian gold
assets on the Australian Securities Exchange ('ASX'), which we
believe will realise the potential of the projects and accordingly
realise the best value for our shareholders. Alongside this, we
have diversified our project portfolio having identified a
significant opportunity to capitalise on commodities that are
critical to the future expansion of the growing battery industry,
which we believe are currently underrepresented - namely cobalt,
nickel and manganese. With a restructured portfolio of strategic
assets, I believe the remainder of 2017 is set to be equally active
for the Company.
Looking first at the gold assets, I would like to take this
opportunity to provide further information on our reasoning for
listing our wholly owned subsidiary Keras (Gold) Australia Pty Ltd
('Keras Australia') on the ASX, through a shell company, Pharmanet
Group Limited ('Pharmanet'). As shareholders will be aware, our
primary focus over the past 12 months has been on advancing this
gold portfolio both in terms of increasing our land holding and
proving up the resource potential. I am pleased to report that we
have had significant success in both respects, creating an enlarged
Warrawoona Gold Project in the East Pilbara Gold Belt of the
Pilbara Goldfield of Western Australia. Warrawoona has a total
Inferred Mineral Resource Inventory of 5.8Mt @ 2.2g/t Au for
410,000oz with significant further upside. This includes Klondyke
and the Copenhagen Deposit.
Whilst we continue to see significant potential for Warrawoona,
we have held the view that these assets should be developed as a
standalone entity, separate from our African interests.
Furthermore, we hold the view that the ASX is a more suitable home
for these assets. Accordingly, we set about identifying a suitable
vehicle and structure to best realise value for shareholders.
As announced on 21 March 2017, ASX quoted Pharmanet has
conditionally agreed to acquire 100% of Keras Australia in exchange
for shares in Pharmanet and raise working capital on ASX. Assuming
that the milestones specified in the agreement between Pharmanet
and Keras are met, Keras will eventually own 724 million Pharmanet
shares at an initial price of A$0.02. By utilising Pharmanet and
building in milestones to be achieved before part of our
shareholding is issued, we are showing our belief in the assets to
new shareholders and ultimately, will maximise value for all
shareholders. Keras board members Dave Reeves and Peter
Hepburn-Brown will be appointed to the Board of Pharmanet as
Managing Director and Non-executive Director respectively.
Pharmanet will also repay the majority of the liability under the
Company's Acquisition Finance Facility, as summarised in the
Company's announcement of 12 September 2016.
Our decision to enter into the Transaction is already proving
well-founded. Pharmanet has received strong interest from investors
interested in Warrawoona, with Pharmanet raising A$620,000 before
expenses (approximately GBP360,000) from sophisticated investors in
Australia via an oversubscribed placing as announced on 18 April
2017. Pharmanet is now seeking to raise A$7.9 million
(approximately GBP4.6 million) to rapidly advance the project by
way of a major drilling and exploration programme and initial
Scoping Studies. We will continue to keep shareholders updated with
progress relating to this, but are pleased that milestone
developments continue to be met on time and Pharmanet remains on
track to relist as Calidus Resources Limited in June 2017.
With a strong balance sheet, experienced board and a defined
development strategy, we believe Calidus is set to become one of
the few independent near term gold development companies on the
ASX. Accordingly, I firmly believe our strategic interest in
Calidus will offer significant value exposure to Keras whilst
removing the burden of capital commitments for project
development.
The Transaction requires the approval of Keras shareholders, and
the General Meeting to consider such approval has been convened for
Wednesday, 24 May 2017. At today's date, proxy votes received are
overwhelmingly in favour of the Transaction.
Looking to Africa, Keras retains an 85% interest in the Nayega
Manganese Project in Togo, which we are confident can deliver
significant value in the near-term. The project has a JORC Code
Compliant Indicated and Measured Resource of 11.0Mt @ 13.1%
manganese and we have completed the majority of the Phase 1
Definitive Feasibility Study to develop an initial open-pit,
250,000tpa manganese operation. To enable this proposed
development, we have applied for a Mining Permit and are currently
awaiting the award of this.
Building upon the positive relations we have built with the Togo
Government, we are delighted to have recently increased our mineral
footprint in country having been granted five exploration licences
over vacant ground that covers known cobalt and nickel
mineralisation. Average rock chips from the mineralised zone have
recovered grades of 0.82% nickel ("Ni") and 0.19% cobalt ("Co"),
with highs of 1.4% Ni and 0.25% Co. This equates to a 4.5g/t
equivalent gold grade based on current metal prices.
We believe these new licences offer a strategic development
opportunity for Keras, given current market dynamics which are
placing significant demand on materials such as lithium, cobalt,
nickel and manganese, which are critical to the rapidly growing
battery market. Indeed, cobalt is often reported as the most
critical metal from a supply perspective for this industry, with a
substantial shortfall expected before 2020 unless additional
capacity is bought online. Accordingly, prices have increased 100%
in the past six months. With cobalt mineralisation already proven
at our new licences, we hope to help address this supply/demand
deficit. Initial exploration work consisting of mapping, sampling,
trenching, alongside the compilation of historical data to prove up
the resource potential is already underway, and we look forward to
keeping the market updated with developments as we advance this
exciting asset.
Financial Review
Keras has recorded a total comprehensive loss for the 6 months
ended 31 March 2017 of GBP1,308,000. The loss was mainly associated
with a small operating loss from the Wycheproof open pit project
and expensing of exploration administrative support expenditure.
Finance costs of GBP432,000 related primarily to the Finance
Agreement described below.
Intangible assets increased to GBP3.5m at 31 March 2017. The
main reason for the increase being the acquisition of in October
2016 of Klondyke. Consideration for the Klondyke acquisition was
settled via the payment of A$1.42m (GBP0.8m) in cash, with the
balance via the issue of 100,000,000 ordinary shares of 0.1p each
("Ordinary Shares") in the Company, at a price of 0.62p being the
closing price on 4 October 2016 (the "Consideration Shares"). The
Consideration Shares are subject to standard lock in and orderly
market terms. In order to fund the Klondyke acquisition the Company
has entered into an Acquisition Finance Facility Agreement
('Finance Agreement') with a consortium of investors arranged by
Riverfort Global Capital Ltd (the 'Investors'). The total drawdown
available before fees to the Company is US$2m (GBP1.5m) ('Principal
Amount') with a maturity date six months after the initial drawdown
at an interest rate of 10% per semi-annum, with a Commitment Fee
and an Implementation Fee of 5% each. As announced on 28 April
2017, pursuant to the Company's plan to list the Australian gold
assets on the ASX, the repayment date of this facility had been
extended
to 1 July 2017.
In February 2017 Keras completed an equity raising of GBP600,000
(before expenses) to support ongoing exploration work at
Warrawoona. Since the end of the period a further equity raising of
GBP530,000 (before expenses) has been completed to provide working
capital for the manganese and cobalt projects in Togo as well as
costs relating to the Transaction.
Outlook
With exposure to cobalt, nickel and manganese, our African
licences provide investors with strategic access to the high growth
battery market. Alongside this, our plans to list our Australian
gold assets in a standalone ASX quoted company provides a clear
structure through which we can gain significant value exposure.
With multiple value upside triggers and diverse commodity exposure
combining the "safe-haven" of gold with the burgeoning battery
market I believe Keras is well poised for growth.
We look forward to continuing to keep shareholders abreast of
developments as we enter this next phase of our growth. I would
like to thank our investors for their support and our board and
management team for their consistent hard work.
Brian Moritz
Chairman
22 May 2017
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
**S**
For further information please visit www.kerasplc.com, follow us
on Twitter @kerasplc or contact the following:
Dave Reeves Keras Resources plc dave@kerasplc.com
Nominated Adviser
Gerry Beaney/David Hignell Northland Capital Partners Limited +44 (0) 20 3861 6625
Broker
Elliot Hance/Jonathon Belliss Beaufort Securities Limited +44 (0) 20 7382 8415
Damon Heath/Erik Woolgar Shard Capital Ltd +44 (0) 20 7186 9952
Tom Curran/Ben Tadd SVS Securities +44 (0) 20 3700 0093
Financial PR
Susie Geliher/Charlotte Page St Brides Partners Limited +44 (0) 20 7236 1177
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHSED 31 MARCH 2017
Re-presented Re-presented
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
GBP'000 GBP'000 GBP'000
Continuing operations
Revenue 941 - 1,936
Cost of
sales (1,048) - (2,242)
-------------- ------------- -------------
Gross
profit (107) - (306)
Administrative and
exploration expenses (604) (615) (1,223)
Loss from operating
activities (711) (615) (1,529)
Finance income - 40 -
Finance
costs (432) (416) (486)
Net finance costs (432) (376) (486)
Impairment of assets - - (10)
Loss before taxation (1,143) (991) (2,025)
Taxation - 135 (117)
-------------- ------------- -------------
Loss from continuing
operations (1,143) (856) (2,142)
-------------- ------------- -------------
Discontinued operations
Loss from discontinued
operations, net of tax 7 (3) (61) (97)
Loss (1,146) (917) (2,239)
Other comprehensive
income
Exchange translation on foreign
operations (162) 167 95
-------------- ------------- -------------
Other comprehensive (loss)/income
for the period, net of tax (162) 167 95
-------------- ------------- -------------
Total comprehensive
loss for the period (1,308) (750) (2,144)
============== ============= =============
Loss attributable
to:
Owners of the Company (2,055) (894) (2,211)
Non-controlling interests 909 (23) (28)
-------------- ------------- -------------
Loss for the year (1,146) (917) (2,239)
============== ============= =============
Total comprehensive
loss attributable to:
Owners of the Company (2,196) (718) (2,075)
Non-controlling interests 888 (32) (69)
-------------- ------------- -------------
Total comprehensive
loss for the year (1,308) (750) (2,144)
============== ============= =============
Loss per share - continuing
operations
Basic and diluted
loss per share (pence) (0.135) (0.076) (0.176)
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2017
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Notes GBP'000 GBP'000 GBP'000
Assets
Non-current assets
Intangible assets 8 3,491 2,361 2,041
Property, plant and
equipment 10 41 34 51
Trade and other receivables 11 29 145 29
3,561 2,540 2,121
------------- ------------- -----------
Current assets
Inventory 12 - - 604
Trade and other receivables 11 26 75 200
Cash and cash equivalents 143 155 134
------------- ------------- -----------
169 230 938
------------- ------------- -----------
Total assets 3,730 2,770 3,059
============= ============= ===========
Equity
Equity attributable to owners
of the Company
Share capital 13 6,494 5,983 6,123
Share premium 13 8,849 6,427 7,666
Other reserves (31) 260 (339)
Retained deficit (14,591) (11,597) (12,387)
------------- ------------- -----------
721 1,073 1,063
Non-controlling interests (142) (693) (730)
------------- ------------- -----------
Total equity 579 380 333
------------- ------------- -----------
Liabilities
Current liabilities
Loans and borrowings 14 2,011 1,036 1,136
Trade and other payables 15 1,140 1,354 1,590
3,151 2,390 2,726
------------- ------------- -----------
Total liabilities 3,151 2,390 2,726
------------- ------------- -----------
Total equity and liabilities 3,730 2,770 3,059
============= ============= ===========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHSED 31 MARCH 2016
Total attributable to owners of the
Company
Share
option/ Foreign Non-controlling
Share Share warrant exchange Accumulated interests Total
capital premium reserve reserve losses Total GBP'000 equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
October
2015 (audited) 5,504 6,371 250 273 (11,275) 1,123 (661) 462
Loss for the
period - - - - (894) (894) (23) (917)
Total other
comprehensive
income - - - (146) 322 176 (9) 167
--------- --------- -------- ---------- ------------- ---------- ----------------- ---------
Total
comprehensive
loss for the
period - - - (146) (572) (718) (32) (750)
Issue of
ordinary
shares 479 56 - - - 535 - 535
Transfer
reserve on
cancellation
of options - - (250) - 250 - - -
Warrants issued
in lieu
of finance
costs - - 133 - - 133 - 133
479 56 (117) - 250 668 - 668
Balance at 31
March
2016
(unaudited) 5,983 6,427 133 127 (11,597) 1,073 (693) 380
========= ========= ======== ========== ============= ========== ================= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
(CONTINUED)
FOR THE SIX MONTHSED 30 SEPTEMBER 2016
Total attributable to owners of the
Company
Share
option/ Exchange Retained Total Non-controlling
Share Share warrant reserve deficit interests Total
capital premium reserve GBP'000 equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
April 2016
(unaudited) 5,983 6,427 133 127 (11,597) 1,073 (693) 380
Loss for the
period - - - (839) (478) (1,317) (5) (1,322)
Total other
comprehensive
income - - - 307 (347) (40) (32) (72)
--------- --------- -------- ---------- ---------- ---------- ----------------- ---------
Total
comprehensive
loss for the
period - - - (532) (825) (1,357) (37) (1,394)
Issue of
ordinary
shares 140 1,250 - - - 1,390 - 1,390
Issue costs - (11) - - - (11) - (11)
Warrants issued
in lieu
of finance
costs - - (32) - - (32) (32)
Transfer in
respect
of warrants
exercised - - (35) - 35 - - -
--------- --------- -------- ---------- ---------- ---------- ----------------- ---------
140 1,239 (67) - 35 1,347 - 1,347
Balance at 30
September
2016 (audited) 6,123 7,666 66 (405) (12,387) 1,063 (730) 333
========= ========= ======== ========== ========== ========== ================= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
(CONTINUED)
FOR THE SIX MONTHSED 31 MARCH 2017
Total attributable to owners of the
Company
Share
option/ Foreign Non-
Share Share warrant exchange Accumulated controlling Total
capital premium reserve reserve losses Total interests equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
October
2016 (audited) 6,123 7,666 66 (405) (12,387) 1,063 (730) 333
Loss for the
period - - - - (2,055) (2,055) 909 (1,146)
Total other
comprehensive
income - - - (45) (96) (141) (21) (162)
--------- --------- -------- ---------- ------------- ---------- ------------- ---------
Total
comprehensive
loss for the
period - - - (45) (2,151) (2,196) 888 (1,308)
Issue of
ordinary
shares 371 1,219 - - - 1,590 - 1,590
Issue costs - (36) - - - (36) - (36)
Share based - - - - - - - -
payment
transactions
Disposal of
subsidiaries
with NCI - - - 353 (53) 300 (300) -
--------- --------- -------- ---------- ------------- ---------- ------------- ---------
371 1,183 - 353 (53) 1,854 (300) 1,554
Balance at 31
March
2017
(unaudited) 6,494 8,849 66 (97) (14,591) 721 (142) 579
========= ========= ======== ========== ============= ========== ============= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHSED 31 MARCH 2017
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
GBP'000 GBP'000 GBP'000
Cash flows from operating
activities
Loss for the period (including
discontinued activities) (714) (676) (1,626)
Adjustments for:
Depreciation and amortisation 72 7 107
Loss on disposal of property, 15 - -
plant and equipment
Foreign exchange differences (221) 17 (90)
Equity-settled share-based - - -
payment transactions
------------- ------------- -----------
(848) (652) (1,609)
Changes in:
- inventories 604 - (604)
- trade and other receivables 174 (23) (177)
- trade and other payables (685) 359 942
------------- ------------- -----------
Cash used in operating
activities (755) (316) (1,448)
Finance income - - -
Finance cost (281) (31) (344)
Taxes paid (69) - -
------------- ------------- -----------
Net cash used in operating
activities (350) (347) (1,792)
------------- ------------- -----------
Cash flows from investing
activities
Acquisition of property,
plant and equipment (2) - (21)
Proceeds from sale of property, - - -
plant and equipment
Exploration expenditure (847) (81) (286)
Net cash used in investing
activities (849) (81) (307)
------------- ------------- -----------
Cash flows from financing
activities
Net proceeds from issue
of share capital 600 70 1,434
Proceeds from short
term borrowings 1,362 449 735
Net cash flows from
financing activities 1,962 519 2,169
------------- ------------- -----------
Net (decrease)/increase
in cash and cash equivalents 8 91 70
Cash and cash equivalents
at beginning of period 134 64 64
Cash acquired with 1 - -
subsidiary
Effect of foreign exchange - - -
rate changes
------------- ------------- -----------
Cash and cash equivalents
at end of period 143 155 134
============= ============= ===========
KERAS RESOURCES PLC
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL
STATEMENTS
FOR THE SIX MONTHSED 31 MARCH 2017
1. Reporting entity
Keras Resources plc is a company domiciled in England and Wales.
The condensed consolidated interim financial statements of the
Company as at and for the six months ended 31 March 2017 comprise
the Company and its subsidiaries (together referred to as the
"Group") and the Group's interests in associates and jointly
controlled entities. The Group currently operates as an explorer
and developer and commenced production at its Australian gold
projects in 2016.
2. Basis of preparation
(a) Statement of compliance
This condensed consolidated interim financial report has been
prepared in accordance with IAS 34 Interim Financial Reporting.
Selected explanatory notes are included to explain events and
transactions that are significant to an understanding of the
changes in financial performance and position of the Group since
the last annual consolidated financial statements as at and for the
year ended 30 September 2016. This condensed consolidated interim
financial report does not include all the information required for
full annual financial statements prepared in accordance with
International Financial Reporting Standards.
This condensed consolidated interim financial report was
approved by the Board of Directors on 19 May 2017.
(b) Judgements and estimates
Preparing the interim financial report requires Management to
make judgements, estimates and assumptions that affect the
application of accounting policies and the reported amounts of
assets and liabilities, income and expense. Actual results may
differ from these estimates.
In preparing this condensed consolidated interim financial
report, significant judgements made by Management in applying the
Group's accounting policies and key sources of estimation
uncertainty were the same as those that applied to the consolidated
financial statements as at and for the year ended 30 September
2016.
3. Significant accounting policies
The accounting policies applied by the Group in this condensed
consolidated interim financial report are the same as those applied
by the Group in its consolidated financial statements as at and for
the year ended 30 September 2016.
4. Financial instruments
Financial risk management
The Group's financial risk management objectives and policies
are consistent with those disclosed in the consolidated financial
statements as at and for the year ended 30 September 2016.
5. Segment information
The Group considers that it operates in two distinct business
areas, being that of manganese exploration and that of gold
exploration and extraction. The extraction of iron ore is now
considered to be a discontinued activity. These business areas form
the basis of the Group's operating segments. For each segment, the
Group's Managing Director (the chief operating decision maker)
reviews internal management reports on at least a quarterly
basis.
Other operations relate to the group's administrative functions
conducted at its head office and by its intermediate holding
company together with consolidation adjustments.
Information regarding the results of each reportable segment is
included below. Performance is measured based on segment profit
before tax, as included in the internal management reports that are
reviewed by the Group's Managing Director. Segment results are used
to measure performance as management believes such information is
the most relevant in evaluating the performance of certain segments
relative to other entities that operate within these
industries.
For the six months ended 31 March 2017 (unaudited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue 941 - - - 941
========== ============= ============= ========== ==========
Loss before tax (263) (3) (34) (846) (1,146)
========== ============= ============= ========== ==========
Segment assets 2,667 - 559 504 3,730
========== ============= ============= ========== ==========
For the six months ended 31 March 2016 (unaudited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue - - - - -
========== ============= ============= ========== ==========
Loss before tax (244) (61) (30) (717) (1,052)
========== ============= ============= ========== ==========
Segment assets 1,317 35 892 526 2,770
========== ============= ============= ========== ==========
For the twelve months ended 30 September 2016 (audited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue 1,936 - - - 1,936
========== ============= ============= ========== ==========
Loss before tax (830) (97) (108) (1,087) (2,122)
========== ============= ============= ========== ==========
Segment assets 1,941 22 575 521 3,059
========== ============= ============= ========== ==========
:
5. Segment information (continued)
Information about geographical
segments:
For the six months ended 31 March 2017 (unaudited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue 941 - - - 941
============ ============== ========= ========== ==========
Profit/(loss)
before tax (263) - (37) (846) (1,146)
============ ============== ========= ========== ==========
Segment assets 2,667 - 559 504 3,730
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP3,000
loss before tax and GBPnil segment assets relating
to discontinued activities.
For the six months ended 31 March 2016 (unaudited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue - - - - -
============ ============== ========= ========== ==========
Loss before tax (206) (18) (105) (723) (1,052)
============ ============== ========= ========== ==========
Segment assets 1,688 9 547 526 2,770
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP43,000
loss and GBP26,000 segment assets relating to
discontinued activities.
For the twelve months ended 30
September 2016 (audited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue 1,936 - - - 1,936
============ ============== ========= ========== ==========
Loss before tax (830) (12) (184) (1,096) (2,122)
============ ============== ========= ========== ==========
Segment assets 1,940 8 589 522 3,059
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP85,000
loss and GBP14,000 segment assets relating to
discontinued activities.
6. Seasonality of operations
The Group is not considered to be subject to seasonal
fluctuations.
7. Discontinued operations
On 17 February 2017 the Group applied to deregister its South
African subsidiary, Moongate 218 (Pty) Limited. An application for
deregistration of Southern Mn (Pty) Ltd will be made in due course.
On 6 January 2017, the Group disposed of its entire 78.3% interest
in Ressource Equatoriales SARL for nil consideration. These actions
were taken by the Group as either the licences had expired or it
was considered that the operations were no longer viable for the
Group. The Group no longer holds iron ore assets. The comparative
consolidated statement of profit or loss and OCI have been
represented to show the discontinued operations separately from
continuing operations.
Results of discontinued operations
6 months 6 months 12 months
31-Mar-17 31-Mar-16
(unaudited) (unaudited) 30-Sep-16
GBP'000 GBP'000 (audited)
GBP'000
Revenue - - -
Cost of sales - - -
------------- -------------- ------------
Gross profit - - -
Administrative and exploration
expenses (3) (61) (97)
Loss from operating
activities (3) (61) (97)
Finance income - - -
Finance costs - - -
Net finance costs - - -
Impairment of assets - - -
Loss before taxation (3) (61) (97)
Taxation - - -
------------- -------------- ------------
Loss from discontinued
operations (3) (61) (97)
------------- -------------- ------------
Cash flows from (used in) discontinued operation
6 months 6 months 12 months
31-Mar-17 31-Mar-16
(unaudited) (unaudited) 30-Sep-16
GBP'000 GBP'000 (audited)
GBP'000
Net cash used in operating - - -
activities
Net cash from investing - - -
activities
------------- -------------- ------------
Net cash flows for - - -
the period
------------- -------------- ------------
7. Discontinued operations (continued)
Effect of disposal on the financial position of the Group
GBP'000
Property, plant and
equipment 15
Trade and other receivables 1
Cash and cash equivalents -
Trade and other payables -
Net assets and liabilities 16
========
Consideration received -
Net cash inflows -
8. Intangible assets
6 months 6 months 12 months
31 Mar 31 Mar 30 Sep
17 16 (unaudited) 16
(unaudited) GBP'000 (audited)
GBP'000 GBP'000
Cost
Balance at beginning of period 6,686 5,590 5,590
Additions 1,631 1,050 790
Disposals (4,705) - -
Effect of movement in exchange
rates 60 140 306
------------- ---------------- -----------
Balance at end of period 3,672 6,780 6,686
============= ================ ===========
Impairment losses
Balance at beginning of period 4,645 4,419 4,419
Impairment - - 10
Amortisation 65 - 88
Disposals (4,532)
Effect of movement in exchange
rates 3 - 128
------------- ---------------- -----------
Balance at end of period 181 4,419 4,645
============= ================ ===========
Carrying amounts
Balance at end of period 3,491 2,361 2,041
====== ====== ======
Balance at beginning of period 2,041 1,171 1,171
====== ====== ======
Intangible assets comprise the fair value of mineral exploration
rights acquired, the cost of explorations studies and goodwill.
9. Business combinations
On 5 October 2016, the Group acquired 100 per cent of the
ordinary share capital of Arcadia Minerals Pty Limited (now renamed
Keras (Pilbara) Gold Pty Limited), an Australian registered private
company. The acquisition was settled by way of cash and a share
issue. The acquisition related to the Klondyke Gold Project.
The transaction has been accounted for using the acquisition
method of accounting.
The details of the business combination are as follows:
Fair
Book value value Fair
GBP'000 adjustments value
GBP'000 GBP'000
Mineral rights 266 1,145 1,411
Fixed assets 8 - 8
Bank balances and
cash 1 - 1
275 1,145 1,420
============= ============= ==========
GBP'000
Satisfied by:
Cash 800
Share consideration 620
1,420
========
10. Property, plant and equipment
Acquisitions and disposals
During the six months ended 31 March 2017 the Group acquired
assets with a cost of GBP10,000 (six months ended 31 March 2016:
GBP6,000, twelve months ended 30 September 2016: GBP27,000).
Assets with a carrying amount of GBP15,000 were disposed of
during the six months ended 31 March 2016 (six months ended 31
March 2016: GBPnil; twelve months ended 30 September 2016: GBPnil),
resulting in a loss on disposal of GBP15,000 (six months ended 31
March 2016: GBP2,000; twelve months ended 30 September 2016:
GBPnil), which is included in 'administrative expenses' in the
condensed consolidated statement of comprehensive income.
11. Trade and other receivables
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Other receivables 41 47 37
Prepayments 14 - 15
55 47 52
============= ============= ===========
Trade receivables and other receivables are stated at their
nominal values less allowances for non recoverability.
12. Inventories
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Minerals held for sale - - 426
Production stockpile - - 178
- - 604
=================== =================== ===========
13. Share capital and reserves
Issue of ordinary shares
On 5 October 2016, 100,000,000 ordinary shares were issued at
GBP0.0062 per share as part of the acquisition of the Klondyke Gold
Project.
On 26 January 2017, 171,428,571 ordinary shares were issued for
cash at GBP0.0035 per share.
On 21 February 2017 99,810,827 ordinary shares were issued at
GBP0.0037 per share in part settlement of the unsecured loan notes
with 8% redemption as detailed in note 14, the balance being
settled in cash.
Warrants
On 5 October 2017, in connection with the finance agreement set
up to acquire the Klondyke Gold Project, GBP389,350 worth of
warrants were granted at a strike price of GBP0.8501, these are
valid for two years from the date of issue.
Dividends
No dividends were declared or paid in the six months ended 31
March 2017 (period ended 31 March 2016: GBPnil, year ended 30
September 2016: GBPnil).
14. Loans and borrowings
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited)
(unaudited) (audited)
Unsecured loan notes - 10% 314 314 314
Unsecured loan notes - 8%
redemption - 457 556
Non-convertible loan 133 265 266
Acquisition Finance facility 1,564 - -
2,011 1,036 1,136
============= ============= ===========
The loan notes carry interest at 10% per annum and are repayable
on demand. This loan was provided to the Company by the Managing
Director David Reeves.
The non-convertible loan relates to the closure of the equity
swap agreement. It is unsecured and was originally scheduled for
repayment on 17 February 2017. This has been extended and is
anticipated to be repaid by June 2017.
The Acquisition Finance Facility Agreement was entered into as a
bridge funding facility to acquire the Klondyke Gold Project. It's
maturity date is six months after initial drawdown, being 3 October
2016, and, prior to maturity, the lender may elect to convert such
principal amount of the loan outstanding at a 20% premium to the
Company's closing share price on the date of drawdown. On 20 March
2017 the Company and the lender agreed to defer repayment of this
facility to the 3 June 2017. A further agreement to defer repayment
up to 1 July 2017 was entered into on the 27 April 2017.
15. Trade and other payables
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Trade payables 471 633 496
Accruals 618 256 579
Other payables 51 465 515
1,140 1,354 1,590
============= ============= ===========
There is no material difference between the fair value of trade
and other payables and their book value.
16. Subsequent events
On 21 March 2017, the Group announced its plans for the proposed
listing of the Company's Australian gold assets on the ASX, this is
subject to obtaining all necessary approvals but it is anticipated
that the listing will take place in Q2 2017. On 8 May 2017 the
Group announced that ASX quoted Pharmanet lodged a prospectus with
the Australian Securities and Investments Commission (the
"Prospectus") on 5 May 2017. The Prospectus has been lodged in
order to raise A$7.9 million (approximately GBP4.6 million) as part
of the proposed acquisition by Pharmanet of 100% of the issued
share capital of the Company's wholly owned subsidiary Keras
Australia as previously announced on 21 March 2017. Pharmanet is
anticipated to relist as Calidus in June 2017.
On 24 April 2017, the Group raised GBP530,000 (before expenses)
from new and existing shareholders through the placing of
151,428,560 ordinary shares of 0.1p each ('Ordinary Shares') at a
placing price of 0.35p per Ordinary Share (the 'Placing Shares')
and the grant of 75,714,280 warrants to subscribe for new Ordinary
Shares (the 'Placing Warrants') (together the 'Placing'). The
Placing Warrants are exercisable at price of 0.5p per warrant,
within a 2-year exercise period and the Placing Warrants are
conditional on passing of the shareholder resolutions at a
forthcoming General Meeting.
On 28 April 2017, the Group announced that it would be holding a
general meeting for Shareholders on the 24 May 2017 relating to the
proposed acquisition of by Pharmanet of 100% of the issued share
capital of the Company's wholly owned subsidiary Keras Australia as
previously announced on 21 March 2017.
The Company also announced an extension to the US$2 million
Acquisition Finance Facility Agreement with the Investors as
originally announced on 12 September 2016. On 21 March 2017 the
Company announced that the maturity date of the Acquisition Finance
Facility had been extended until 3 June 2017 (the "Deferral
Agreement"). The Deferral Agreement was subsequently amended on 28
April 2017 to extend the maturity date by a further month until 1
July 2017 to allow time for the Transaction to complete.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR LLFIFEEILFID
(END) Dow Jones Newswires
May 22, 2017 02:00 ET (06:00 GMT)
Keras Resources (LSE:KRS)
Historical Stock Chart
From Apr 2024 to May 2024
Keras Resources (LSE:KRS)
Historical Stock Chart
From May 2023 to May 2024